Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Celularity Inc (CELU)

Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Celularity Inc. Resolves Nasdaq Compliance Issue, Continues Trading on Nasdaq Stock Market

Celularity Inc. resolved its Nasdaq compliance issue, ensuring continued listing after curing filing delinquencies.Quiver AI SummaryCelularity Inc. announced that its hearing regarding non-compliance with...

CELU : 2.77 (+12.60%)
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Provides Corporate Update

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Reboundâ„¢ Product from Sequence LifeScience, Inc.

CELU : 2.77 (+12.60%)
CELUW : 0.0250 (unch)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Celularity Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

CELU : 2.77 (+12.60%)
CELULARITY ANNOUNCES $45 MILLION PURCHASE ORDER, FIRST MIDDLE EAST PRIVATE LABEL AGREEMENT FOR CELULARITY'S HALAL-CERTIFIED BIOMATERIAL PRODUCTS

/PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial...

CELU : 2.77 (+12.60%)
Celularity Announces Agreement with AD Ports Group for Exclusive Product Distribution in Various Territories in the GCC and Egypt

/PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a biotechnology company developing placental-derived allogenic cell therapies and biomaterial...

CELU : 2.77 (+12.60%)

Barchart Exclusives

Is It Time to Buy This Dividend Stock With Nuclear Energy Upside?
Apart from its prowess in nuclear energy, this energy company is also deploying AI. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar